by Keyword: Chitosan/pegda based scaffolds
Soriente, A, Amodio, SP, Fasolino, I, Raucci, MG, Demitri, C, Engel, E, Ambrosio, L, (2022). ANTI-INFLAMMATORY, PRO-ANGIOGENIC AND OSTEOGENIC PROPERTIES OF CS SCAFFOLD FOR BONE FRACTURE TREATMENT (Abstract 899) Tissue Engineering Part a 28, S253
Several studies are aimed at developing systems based on naturaland biocompatible polymers for bone tissue engineering. Here, weemphasized how the bio-activation of chitosan (CS)-based scaffoldsby organic and inorganic signals is able to promote osteogenesis,angiogenesis and to modulate the inflammation response by usingin vitro models to mimic bone fracture microenvironment. CSscaffolds by using two different approaches based on inorganic andorganic compounds, were bio-activated respectively1. The expres-sion of inflammatory mediators was investigated (TGF-band IL-6).Additionally, to assess the effect of CS scaffold on angiogenesis,CD31 expression, cell adhesion, proliferation, migration and tubeformation by HUVECs were detected. The results highlighted thatinorganic and organic signals promote cell proliferation and differ-entiation without significant differences between the material groups.In particular, scaffolds bio-activated by using inorganic signals(hydroxyapatite nanoparticles) inhibit pro-inflammatory mediator’sproduction (IL-1band IL-6), induce anti-inflammatory cytokinegeneration (IL-10) and reduce nitric monoxide metabolites (nitrites).Conversely, scaffolds bio-activated by using organic signals (BMP-2mimicking peptide) were able to decrease pro-inflammatory markerswithout any effect on anti-inflammatory cytokines levels and on ni-trites. Furthermore, scaffolds promote angiogenesis by increasingcell proliferation, migration and tube formation with best resultsobtained for BMP based-scaffolds. Our results support the conceptthat CS biomaterials may be novel multi-target devices to treat bonerelated inflammation stimulating neo-vascularization of tissue-en-gineered constructs.ACKNOWLEDGEMENTS: The study was supported by OPENLAB. The authors thank Mariarosaria Bonetti for lab technicalsupport & data elaboration and Dr. Roberta Marzella for support toproject management.
JTD Keywords: Angiogenesis, Chitosan/pegda based scaffolds, Osteogenesis
Soriente A, Amodio SP, Fasolino I, Raucci MG, Demitri C, Engel E, Ambrosio L, (2021). Chitosan/PEGDA based scaffolds as bioinspired materials to control in vitro angiogenesis Materials Science & Engineering C-Materials For Biological Applications 118,
© 2020 Elsevier B.V. In the current work, our purpose was based on the assessment of bioactive chitosan (CS)/Poly(ethylene glycol) diacrylate (PEGDA) based scaffolds ability to stimulate in vitro angiogenesis process. The bioactivation of the scaffolds was accomplished by using organic (BMP-2 peptide) and inorganic (hydroxyapatite nanoparticles) cues. In particular, the properties of the materials in terms of biological response promotion on human umbilical vein endothelial cells (HUVECs) were studied by using in vitro angiogenesis tests based on cell growth and proliferation. Furthermore, our interest was to examine the scaffolds capability to modulate two important steps involved in angiogenesis process: migration and tube formation of cells. Our data underlined that bioactive signals on CS/PEGDA scaffolds surface induce a desirable effect on angiogenic response concerning angiogenic marker expression (CD-31) and endothelial tissue formation (tube formation). Taken together, the results emphasized the concept that bioactive CS/PEGDA scaffolds may be novel implants for stimulating neovascularization of tissue-engineered constructs in regenerative medicine field.
JTD Keywords: angiogenesis, bmp-2 peptide, chitosan/pegda based scaffolds, human umbilical vein endothelial cells huvecs, Angiogenesis, Bmp-2 peptide, Chitosan/pegda based scaffolds, Human umbilical vein endothelial cells huvecs, Osteogenesis